Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ependymoma
Related studies linked through entity extraction aliases.
Selumetinib for NF2-Related Schwannomatosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
- Status
- RECRUITING
- Phase
- PHASE2
B7-H3.CD28Z.CART in CNS Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
- Status
- RECRUITING
- Phase
- N/A
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
In Vitro Models From Pediatric Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Status
- RECRUITING
- Phase
- PHASE1
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
- Status
- TERMINATED
- Phase
- N/A
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1